Colombia INVIMA: 4,582 Importers, 80% Imports — Who Controls Device Access?

Executive Summary

Colombia imports more than 80% of its medical devices, making the importer and legal representative (apoderado) the two most important gatekeepers for market access. INVIMA — the Instituto Nacional de Vigilancia de Medicamentos y Alimentos — requires every device registration to list the importer(s) and, for foreign manufacturers, an apoderado (legal representative) who interfaces with the regulator on the manufacturer's behalf.

Our analysis of the complete INVIMA device registration dataset (extracted March 2026, 423,394 role-level records) reveals a fragmented but strategically important channel landscape: 4,582 unique importers and 2,537 unique apoderados compete across the registry, yet the top 15 importers hold only 16.4% of import records and the top 15 apoderados hold 29.1% of representative records. Colombia-based titulares (registration holders) account for 64.1% of all rows — but this includes Colombian subsidiaries of multinationals, not just domestic manufacturers. The data reveals a market where channel access is distributed but where individual apoderados can control significant registration portfolios, creating meaningful lock-in risk for foreign manufacturers.

This article quantifies the importer and apoderado concentration, maps the manufacturer-country mix, and explains why channel partner selection in Colombia is a regulatory risk decision, not just a commercial one.

Data Source and Method

• Source: Colombia INVIMA public device registration database
• Analysis sample: INVIMA device registry extract dated March 2026 (423,394 role-level records)
• Scope: All device registrations with role assignments (IMPORTADOR, APODERADO, FABRICANTE, ACONDICIONADOR, etc.)
• Analysis date: 9 June 2026
• Computed using: MedDeviceGuide analysis of the INVIMA public registry extract
• Limitations: The INVIMA registry is role-denormalized — a single device registration may appear as multiple rows (one per role holder). Counts reflect role-level rows, not unique device registrations. The manufacturer country (PAIS_TITULAR) reflects the registration holder's country, which may be a local subsidiary rather than the country of manufacture. Comparisons should use unique EXPEDIENTE (case file number) counts where noted.

The INVIMA Registry at a Glance

69.2% of records are in Vigente (active) status. The 23.4% expired rate reflects the natural turnover of 10-year registration validity periods — a healthy renewal cycle for a mature registry.

Device Categories

Medical-surgical devices dominate at 73.6%. IVD-related categories (diagnostic reagents and in vitro reagents) together account for 26.2% — a significant share that reflects Colombia's growing diagnostic testing infrastructure.

Risk Level Distribution

Note that Colombia's INVIMA uses a mixed classification system: medical devices follow EU-style I/IIa/IIb/III classification, while IVDs use Class I/II/III. The "II" category (10.7%) reflects IVD Class II devices.

Role Distribution: Who Does What in the Registry

Each INVIMA registration assigns one or more roles to the entities involved:

The four dominant roles — manufacturer, importer, packager/conditioner, and legal representative — account for 89.6% of all records. The APODERADO role is critical for foreign manufacturers: it is the legally mandated in-country representative who signs the registration dossier, receives INVIMA communications, and carries responsibility for post-market compliance on behalf of the overseas manufacturer.

Manufacturer-Country Mix: Colombia Dominates as Titular

The PAIS_TITULAR field identifies the country of the registration holder (titular):

Colombia's 64.1% share reflects that many multinational device companies operate through Colombian subsidiaries that hold the registration (e.g., Abbott Laboratories de Colombia, 3M Colombia, Productos Roche). The US at 17.7% captures American-headquartered firms that retain their own registrations. Liechtenstein's 1.8% share is almost entirely attributable to the Ivoclar Vivadent group, which is headquartered in Schaan.

Modalidad (Market Pathway)

81.8% of registrations follow the "Import & Sell" pathway, confirming Colombia's overwhelming import dependency. Only 8.0% of registrations involve domestic manufacturing.

Importer Concentration: Fragmented but Strategic

The INVIMA registry lists 4,582 unique importers across 96,499 import records. The concentration is low:

The top 15 importers hold only 16.4% of import records — a remarkably low concentration. The market is deeply fragmented, with thousands of small and mid-size importers each handling a handful of registrations.

However, the unique registration count tells a different story. Abbott Laboratories de Colombia appears as importer on 975 unique registrations — meaning it is the designated importer for nearly 1,000 separate device registrations. Annar Diagnostica (combined variants) handles over 1,400 unique registrations. These are institutional importers that serve as gateways for large device portfolios.

Implication: Switching Importers Requires Registration Amendment

Under INVIMA's regulations (Decree 4725/2005), the importer is named on the registration certificate. Changing importers requires a formal registration amendment (modificación), which involves documentation, fees, and INVIMA processing time. This creates practical lock-in: while the market has thousands of importers, switching away from a large-volume importer is not a simple commercial decision — it is a regulatory process.

Apoderado Concentration: Individuals, Not Corporations

The apoderado role is fundamentally different from the importer role. Where importers are typically corporations, apoderados are often individual professionals — lawyers, regulatory consultants, or pharmacists who serve as the manufacturer's legal representative before INVIMA. The data shows 2,537 unique apoderados across 48,996 records:

The top 15 apoderados control 29.1% of all apoderado records — notably more concentrated than the importer landscape. Combining the two Rubiela Arias de Fajardo entries (likely the same individual with a minor spelling variant), the single largest apoderado controls 3,116 records across 1,190 unique registrations — representing access to over 1,000 separate device registrations.

A critical observation: several top apoderados have very few unique registrations despite high record counts (e.g., Raúl Camilo Tellez Ruiz: 1,672 records but only 1 unique registration; Mary Luz Tibabijo Mejia: 720 records but only 4 unique registrations). This pattern suggests these individuals are listed as apoderado across many individual product lines or pack sizes within the same registration family, rather than spanning many different registrations.

Conversely, apoderados like Tatiana Cespedes Arboleda (779 unique registrations) and Rubiela Arias de Fajardo (1,190 combined unique registrations) are truly high-volume representatives handling hundreds of different manufacturers' registrations.

Device vs. IVD Split

IVD registrations account for 26.2% of all records — a substantial share for a market where INVIMA recently updated its UDI-DI requirements. INVIMA's 2026 UDI-DI guidance (per Resolution 1405/2022, Article 15) mandates that Class IIa devices registered before February 2024 must incorporate UDI-DI coding, with a compliance deadline of February 9, 2026.

Practical Implications for Foreign Manufacturers

1. Apoderado Selection Is Higher-Risk Than Importer Selection

The apoderado concentration data shows that a small number of individual professionals handle a disproportionate share of registrations. If a top apoderado retires, changes firms, or has a compliance issue, the impact cascades across hundreds of registrations. Manufacturers should:

• Verify that their apoderado maintains current INVIMA credentials
• Negotiate contractual provisions for orderly transfer of representation
• Consider whether a corporate apoderado (law firm or regulatory consultancy) provides more continuity than an individual

2. Importer Fragmentation Is a Feature, Not a Bug

With 4,582 importers, Colombia offers ample choice for market-entry channel partners. However, the requirement that importers hold a Storage and Conditioning Certification (CCAA — Certificado de Capacidad de Almacenamiento y Acondicionamiento, per Resolution 4002/2007) creates a quality floor. Manufacturers should verify CCAA status and warehouse conditions before appointing an importer.

3. Registration Holder Strategy Matters

The 64.1% Colombian-registered titular share means that the most common market-entry model is for the local subsidiary or distributor to hold the registration. Foreign manufacturers who retain titular status through their own Colombian entity have more control but must maintain local infrastructure. Those who delegate titular status to a distributor cede registration ownership — and switching distributors then requires a full registration transfer.

4. INVIMA's UDI-DI Rollout Creates an Administrative Burden Window

With UDI-DI requirements now in effect for Class IIa devices (February 2026 deadline) and expanding to additional classes, the 4,582 importers and 2,537 apoderados face a wave of registration amendments. Manufacturers should confirm that their Colombian partners have the capacity to handle UDI-DI incorporation across their portfolios.

Source Notes

• Data source: Colombia INVIMA public device registration database; analysis by MedDeviceGuide, run date 2026-06-09.
• Analysis sample: INVIMA registry extract dated March 2026, 423,394 role-level records.
• Role definitions: IMPORTADOR (importer), APODERADO (legal representative/attorney-in-fact), FABRICANTE (manufacturer), ACONDICIONADOR (packager/conditioner), REPRESENTANTE LEGAL (legal representative entity).
• INVIMA regulatory basis: Decree 4725/2005 (medical devices), Decree 3770/2004 (IVDs), Resolution 1405/2022 (UDI-DI), Resolution 4002/2007 (CCAA storage certification).
• Market size: Approximately USD 1.5 billion for medical devices, USD 0.29 billion for IVDs (MedDeviceGuide estimate based on publicly available industry reports).